A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
NCT03707340
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Hyposexual Desire Disorder
Interventions
DRUG:
Flibanserin Pill
Sponsor
Memorial Sloan Kettering Cancer Center